{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:25:04Z","timestamp":1774085104883,"version":"3.50.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,8,25]],"date-time":"2009-08-25T00:00:00Z","timestamp":1251158400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1038\/sj.bjc.6605225","type":"journal-article","created":{"date-parts":[[2009,8,25]],"date-time":"2009-08-25T20:00:17Z","timestamp":1251230417000},"page":"973-982","source":"Crossref","is-referenced-by-count":101,"title":["Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas"],"prefix":"10.1038","volume":"101","author":[{"given":"O","family":"Martinho","sequence":"first","affiliation":[]},{"given":"A","family":"Longatto-Filho","sequence":"additional","affiliation":[]},{"given":"M B K","family":"Lambros","sequence":"additional","affiliation":[]},{"given":"A","family":"Martins","sequence":"additional","affiliation":[]},{"given":"C","family":"Pinheiro","sequence":"additional","affiliation":[]},{"given":"A","family":"Silva","sequence":"additional","affiliation":[]},{"given":"F","family":"Pardal","sequence":"additional","affiliation":[]},{"given":"J","family":"Amorim","sequence":"additional","affiliation":[]},{"given":"A","family":"Mackay","sequence":"additional","affiliation":[]},{"given":"F","family":"Milanezi","sequence":"additional","affiliation":[]},{"given":"N","family":"Tamber","sequence":"additional","affiliation":[]},{"given":"K","family":"Fenwick","sequence":"additional","affiliation":[]},{"given":"A","family":"Ashworth","sequence":"additional","affiliation":[]},{"given":"J S","family":"Reis-Filho","sequence":"additional","affiliation":[]},{"given":"J M","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"R M","family":"Reis","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,8,25]]},"reference":[{"key":"BF6605225_CR1","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1309\/448YRWNC43TE32KQ","volume":"123","author":"ME Alonso","year":"2005","unstructured":"Alonso ME, Bello MJ, Arjona D, Martinez-Glez V, de Campos JM, Isla A, Kusak E, Vaquero J, Gutierrez M, Sarasa JL, Rey JA (2005) Real-time quantitative PCR analysis of gene dosages reveals gene amplification in low-grade oligodendrogliomas. Am J Clin Pathol 123: 900\u2013906","journal-title":"Am J Clin Pathol"},{"key":"BF6605225_CR2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/01.pas.0000177799.58336.1a","volume":"14","author":"D Arjona","year":"2005","unstructured":"Arjona D, Bello MJ, Alonso ME, Isla A, de Campos JM, Vaquero J, Sarasa JL, Gutierrez M, Rey JA (2005) Real-time quantitative PCR analysis of regions involved in gene amplification reveals gene overdose in low-grade astrocytic gliomas. Diagn Mol Pathol 14: 224\u2013229","journal-title":"Diagn Mol Pathol"},{"key":"BF6605225_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/labinvest.3700495","volume":"87","author":"E Arriola","year":"2007","unstructured":"Arriola E, Lambros MBK, Jones C, Dexter T, Mackay A, Tan DSP, Tamber N, Fenwick K, Ashworth A, Dowsett M, Reis JS (2007) Evaluation of Phi29-based whole-genome amplification for microarray-based comparative genomic hybridisation. Lab Invest 87: 75\u201383","journal-title":"Lab Invest"},{"key":"BF6605225_CR4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/labinvest.2008.19","volume":"88","author":"E Arriola","year":"2008","unstructured":"Arriola E, Marchi\u00f2 C, Tan DS, Drury SC, Lambros MB, Natrajan R, Rodriguez-Pinilla SM, Mackay A, Tamber N, Fenwick K, Jones C, Dowsett M, Ashworth A, Reis-Filho JS (2008) Genomic analysis of the HER2\/TOP2A amplicon in breast cancer and breast cancer cell lines. Lab Invest 88: 491\u2013503","journal-title":"Lab Invest"},{"key":"BF6605225_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00401-004-0936-x","volume":"109","author":"D Basto","year":"2005","unstructured":"Basto D, Trovisco V, Lopes JM, Martins A, Pardal F, Soares P, Reis RM (2005) Mutation analysis of B-RAF gene in human gliomas. Acta Neuropathol (Berlin) 109: 207\u2013210","journal-title":"Acta Neuropathol (Berlin)"},{"key":"BF6605225_CR6","doi-asserted-by":"publisher","first-page":"20007","DOI":"10.1073\/pnas.0710052104","volume":"104","author":"R Beroukhim","year":"2007","unstructured":"Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D, Vivanco I, Lee JC, Huang JH, Alexander S, Du J, Kau T, Thomas RK, Shah K, Soto H, Perner S, Prensner J, DeBiasi RM, Demichelis F, Hatton C, Rubin MA, Garraway LA, Nelson SF, Liau L, Mischel PS, Cloughesy TF, Meyerson M, Golub TA, Lander ES, Mellinghoff IK, Sellers WR (2007) Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci USA 104: 20007\u201320012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"BF6605225_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000121020","volume":"24","author":"P Black","year":"1996","unstructured":"Black P, Carroll R, Glowacka D (1996) Expression of platelet-derived growth factor transcripts in medulloblastomas and ependymomas. Pediatr Neurosurg 24 (2): 74\u201378","journal-title":"Pediatr Neurosurg"},{"key":"BF6605225_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/35077225","volume":"411","author":"P Blume-Jensen","year":"2001","unstructured":"Blume-Jensen P, Hunter T (2001) Oncogenic kinase signalling. Nature 411: 355\u2013365","journal-title":"Nature"},{"key":"BF6605225_CR9","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/CCO.0b013e3282f0313b","volume":"19","author":"D Brandsma","year":"2007","unstructured":"Brandsma D, van den Bent MJ (2007) Molecular targeted therapies and chemotherapy in malignant gliomas. Curr Opin Oncol 19: 598\u2013605","journal-title":"Curr Opin Oncol"},{"key":"BF6605225_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrd839","volume":"1","author":"R Capdeville","year":"2002","unstructured":"Capdeville R, Buchdunger E, Zimmermann J, Matter A (2002) Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov 1: 493\u2013502","journal-title":"Nat Rev Drug Discov"},{"key":"BF6605225_CR11","doi-asserted-by":"publisher","first-page":"R788","DOI":"10.1186\/bcr1304","volume":"7","author":"I Carvalho","year":"2005","unstructured":"Carvalho I, Milanezi F, Martins A, Reis RM, Schmitt F (2005) Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression. Breast Cancer Res 7: R788\u2013R795","journal-title":"Breast Cancer Res"},{"key":"BF6605225_CR12","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ygeno.2006.12.012","volume":"89","author":"BP Coe","year":"2007","unstructured":"Coe BP, Ylstra B, Carvalho B, Meijer GA, Macaulay C, Lam WL (2007) Resolving the resolution of array CGH. Genomics 89: 647\u2013653","journal-title":"Genomics"},{"key":"BF6605225_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1056\/NEJMoa020461","volume":"347","author":"GD Demetri","year":"2002","unstructured":"Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD, Joensuu H (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347: 472\u2013480","journal-title":"N Engl J Med"},{"key":"BF6605225_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11060-006-9302-2","volume":"83","author":"A Desjardins","year":"2007","unstructured":"Desjardins A, Quinn JA, Vredenburgh JJ, Sathornsumetee S, Friedman AH, Herndon JE, McLendon RE, Provenzale JM, Rich JN, Sampson JH, Gururangan S, Dowell JM, Salvado A, Friedman HS, Reardon DA (2007) Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas. J Neuro Oncol 83: 53\u201360","journal-title":"J Neuro Oncol"},{"key":"BF6605225_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/00006123-199802000-00080","volume":"42","author":"F Di Rocco","year":"1998","unstructured":"Di Rocco F, Carroll RS, Zhang J, Black PM (1998) Platelet-derived growth factor and its receptor expression in human oligodendrogliomas. Neurosurgery 42: 341\u2013346","journal-title":"Neurosurgery"},{"key":"BF6605225_CR16","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M (2001) Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 344: 1038\u20131042","journal-title":"N Engl J Med"},{"key":"BF6605225_CR17","first-page":"4550","volume":"52","author":"TP Fleming","year":"1992","unstructured":"Fleming TP, Saxena A, Clark WC, Robertson JT, Oldfield EH, Aaronson SA, Ali IU (1992) Amplification and\/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res 52: 4550\u20134553","journal-title":"Cancer Res"},{"key":"BF6605225_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nec.2006.10.006","volume":"18","author":"EI Fomchenko","year":"2007","unstructured":"Fomchenko EI, Holland EC (2007) Platelet-derived growth factor-mediated gliomagenesis and brain tumor recruitment. Neurosurg Clin N Am 18: 39\u201358","journal-title":"Neurosurg Clin N Am"},{"key":"BF6605225_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1136\/jcp.2007.047043","volume":"61","author":"AL Gomes","year":"2008","unstructured":"Gomes AL, Gouveia A, Capelinha AF, de la CD, Silva P, Reis RM, Pimenta A, Lopes JM (2008) Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series. J Clin Pathol 61: 203\u2013208","journal-title":"J Clin Pathol"},{"key":"BF6605225_CR20","first-page":"399","volume":"29","author":"AL Gomes","year":"2007","unstructured":"Gomes AL, Reis-Filho JS, Lopes JM, Martinho O, Lambros MB, Martins A, Schmitt F, Pardal F, Reis RM (2007) Molecular alterations of KIT oncogene in gliomas. Cell Oncol 29: 399\u2013408","journal-title":"Cell Oncol"},{"key":"BF6605225_CR21","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00432-006-0109-5","volume":"132","author":"D Gross","year":"2006","unstructured":"Gross D, Bernhardt G, Buschauer A (2006) Platelet-derived growth factor receptor independent proliferation of human glioblastoma cells: selective tyrosine kinase inhibitors lack antiproliferative activity. J Cancer Res Clin Oncol 132: 589\u2013599","journal-title":"J Cancer Res Clin Oncol"},{"key":"BF6605225_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc1360","volume":"4","author":"A Gschwind","year":"2004","unstructured":"Gschwind A, Fischer OM, Ullrich A (2004) Timeline\u2014The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat Rev Cancer 4: 361\u2013370","journal-title":"Nat Rev Cancer"},{"key":"BF6605225_CR23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ijc.2910600206","volume":"60","author":"A Guha","year":"1995","unstructured":"Guha A, Dashner K, Black PM, Wagner JA, Stiles CD (1995) Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop. Int J Cancer 60: 168\u2013173","journal-title":"Int J Cancer"},{"key":"BF6605225_CR24","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/gcc.20575","volume":"47","author":"R Gunnarsson","year":"2008","unstructured":"Gunnarsson R, Staaf J, Jansson M, Ottesen AM, Goransson H, Liljedahl U, Ralfkiaer U, Mansouri M, Buhl AM, Smedby KE, Hjalgrim H, Syvanen AC, Borg A, Isaksson A, Jurlander J, Juliusson G, Rosenquist R (2008) Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia--a comparative study of four differently designed, high resolution microarray platforms. Genes Chromosomes Cancer 47: 697\u2013711","journal-title":"Genes Chromosomes Cancer"},{"key":"BF6605225_CR25","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1038\/sj.onc.1209497","volume":"25","author":"D H\u00e4gerstrand","year":"2006","unstructured":"H\u00e4gerstrand D, Hesselager G, Achterberg S, Wickenberg Bolin U, Kowanetz M, Kastemar M, Heldin CH, Isaksson A, Nist\u00e9r M, Ostman A (2006) Characterization of an imatinib-sensitive subset of high-grade human glioma cultures. Oncogene 25: 4913\u20134922","journal-title":"Oncogene"},{"key":"BF6605225_CR26","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/ijc.20525","volume":"112","author":"C Hartmann","year":"2004","unstructured":"Hartmann C, Xu X, Bartels G, Holtkamp N, Gonzales IA, Tallen G, von Deimling A (2004) Pdgfr-alpha in 1p\/19q LOH oligodendrogliomas. Int J Cancer 112: 1081\u20131082","journal-title":"Int J Cancer"},{"key":"BF6605225_CR27","first-page":"3213","volume":"52","author":"M Hermanson","year":"1992","unstructured":"Hermanson M, Funa K, Hartman M, Claesson Welsh L, Heldin CH, Westermark B, Nister M (1992) Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52: 3213\u20133219","journal-title":"Cancer Res"},{"key":"BF6605225_CR28","first-page":"164","volume":"56","author":"M Hermanson","year":"1996","unstructured":"Hermanson M, Funa K, Koopmann J, Maintz D, Waha A, Westermark B, Heldin CH, Wiestler OD, Louis DN, von Deimling A, Nister M (1996) Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas. Cancer Res 56: 164\u2013171","journal-title":"Cancer Res"},{"key":"BF6605225_CR29","doi-asserted-by":"publisher","first-page":"7748","DOI":"10.1073\/pnas.85.20.7748","volume":"85","author":"M Hermansson","year":"1988","unstructured":"Hermansson M, Nister M, Betsholtz C, Heldin CH, Westermark B, Funa K (1988) Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Proc Natl Acad Sci USA 85: 7748\u20137752","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6605225_CR30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1215\/15228517-2007-009","volume":"9","author":"N Holtkamp","year":"2007","unstructured":"Holtkamp N, Ziegenhagen N, Malzer E, Hartmann C, Giese A, von Deimling A (2007) Characterization of the amplicon on chromosomal segment 4q12 in glioblastoma multiforme. Neuro Oncol 9: 291\u2013297","journal-title":"Neuro Oncol"},{"key":"BF6605225_CR31","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1093\/bioinformatics\/btm359","volume":"23","author":"J Huang","year":"2007","unstructured":"Huang J, Gusnanto A, O\u2032Sullivan K, Staaf J, Borg A, Pawitan Y (2007) Robust smooth segmentation approach for array CGH data analysis. Bioinformatics 23: 2463\u20132469","journal-title":"Bioinformatics"},{"key":"BF6605225_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neuron.2006.06.012","volume":"51","author":"EL Jackson","year":"2006","unstructured":"Jackson EL, Garcia-Verdugo JM, Gil-Perotin S, Roy M, Quinones-Hinojosa A, VandenBerg S, Alvarez-Buylla A (2006) PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron 51: 187\u2013199","journal-title":"Neuron"},{"key":"BF6605225_CR33","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/path.1823","volume":"207","author":"H Joensuu","year":"2005","unstructured":"Joensuu H, Puputti M, Sihto H, Tynninen O, Nupponen NN (2005) Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme. J Pathol 207: 224\u2013231","journal-title":"J Pathol"},{"key":"BF6605225_CR34","first-page":"627","volume":"7","author":"T Kumabe","year":"1992","unstructured":"Kumabe T, Sohma Y, Kayama T, Yoshimoto T, Yamamoto T (1992) Amplification of alpha-platelet-derived growth factor receptor gene lacking an exon coding for a portion of the extracellular region in a primary brain tumor of glial origin. Oncogene 7: 627\u2013633","journal-title":"Oncogene"},{"key":"BF6605225_CR35","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3171\/jns.2001.95.2.0190","volume":"95","author":"M Lacroix","year":"2001","unstructured":"Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95: 190\u2013198","journal-title":"J Neurosurg"},{"key":"BF6605225_CR36","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/labinvest.3700390","volume":"86","author":"MB Lambros","year":"2006","unstructured":"Lambros MB, Simpson PT, Jones C, Natrajan R, Westbury C, Steele D, Savage K, Mackay A, Schmitt FC, Ashworth A, Reis-Filho JS (2006) Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization. Lab Invest 86: 398\u2013408","journal-title":"Lab Invest"},{"key":"BF6605225_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11060-007-9513-1","volume":"87","author":"ML Liang","year":"2008","unstructured":"Liang ML, Ma J, Ho M, Solomon L, Bouffet E, Rutka JT, Hawkins C (2008) Tyrosine kinase expression in pediatric high grade astrocytoma. J Neuro Oncol 87: 247\u2013253","journal-title":"J Neuro Oncol"},{"key":"BF6605225_CR38","first-page":"3729","volume":"62","author":"NA Lokker","year":"2002","unstructured":"Lokker NA, Sullivan CM, Hollenbach SJ, Israel MA, Giese NA (2002) Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res 62: 3729\u20133735","journal-title":"Cancer Res"},{"key":"BF6605225_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.pathol.1.110304.100043","volume":"1","author":"DN Louis","year":"2006","unstructured":"Louis DN (2006) Molecular pathology of malignant gliomas. Annu Rev Pathol 1: 97\u2013117","journal-title":"Annu Rev Pathol"},{"key":"BF6605225_CR40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica 114: 97\u2013109","journal-title":"Acta Neuropathologica"},{"key":"BF6605225_CR41","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3171\/jns.1991.75.3.0447","volume":"75","author":"TB Mapstone","year":"1991","unstructured":"Mapstone TB (1991) Expression of platelet-derived growth factor and transforming growth factor and their correlation with cellular morphology in glial tumors. J Neurosurg 75: 447\u2013451","journal-title":"J Neurosurg"},{"key":"BF6605225_CR42","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/path.2368","volume":"215","author":"C Marchi\u00f2","year":"2008","unstructured":"Marchi\u00f2 C, Iravani M, Natrajan R, Lambros MB, Savage K, Tamber N, Fenwick K, Mackay A, Senetta R, Di PS, Schmitt FC, Bussolati G, Ellis LO, Ashworth A, Sapino A, Reis-Filho JS (2008a) Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast. J Pathol 215: 398\u2013410","journal-title":"J Pathol"},{"key":"BF6605225_CR43","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/path.2423","volume":"216","author":"C Marchi\u00f2","year":"2008","unstructured":"Marchi\u00f2 C, Natrajan R, Shiu KK, Lambros MB, Rodriguez-Pinilla SM, Tan DS, Lord CJ, Hungermann D, Fenwick K, Tamber N, Mackay A, Palacios J, Sapino A, Buerger H, Ashworth A, Reis-Filho JS (2008b) The genomic profile of HER2-amplified breast cancers: the influence of ER status. J Pathol 216: 399\u2013407","journal-title":"J Pathol"},{"key":"BF6605225_CR44","doi-asserted-by":"crossref","unstructured":"Mackay A, Tamber N, Fenwick K, Iravani M, Grigoriadis A, Dexter T, Lord CJ, Reis-Filho JS, Ashworth A (2009) A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines. Breast Cancer Res Treat (e-pub ahead of print 24 January 2009)","DOI":"10.1007\/s10549-008-0296-7"},{"key":"BF6605225_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1172\/JCI114675","volume":"86","author":"M Maxwell","year":"1990","unstructured":"Maxwell M, Naber SP, Wolfe HJ, Galanopoulos T, Hedley-Whyte ET, Black PM, Antoniades HN (1990) Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. J Clin Invest 86: 131\u2013140","journal-title":"J Clin Invest"},{"key":"BF6605225_CR46","first-page":"1009","volume":"8","author":"HB Newton","year":"2007","unstructured":"Newton HB (2007) Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors. Curr Opin Invest Drugs 8: 1009\u20131021","journal-title":"Curr Opin Invest Drugs"},{"key":"BF6605225_CR47","first-page":"1009","volume":"8","author":"HB Newton","year":"2007","unstructured":"Newton HB (2007) Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors. Curr Opin Invest Drugs 8: 1009\u20131021","journal-title":"Curr Opin Invest Drugs"},{"key":"BF6605225_CR48","doi-asserted-by":"crossref","first-page":"16755","DOI":"10.1016\/S0021-9258(18)55365-5","volume":"266","author":"M Nister","year":"1991","unstructured":"Nister M, Claesson-Welsh L, Eriksson A, Heldin CH, Westermark B (1991) Differential expression of platelet-derived growth factor receptors in human malignant glioma cell lines. J Biol Chem 266: 16755\u201316763","journal-title":"J Biol Chem"},{"key":"BF6605225_CR49","first-page":"3910","volume":"48","author":"M Nister","year":"1988","unstructured":"Nister M, Libermann TA, Betsholtz C, Pettersson M, Claesson Welsh L, Heldin CH, Schlessinger J, Westermark B (1988) Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. Cancer Res 48: 3910\u20133918","journal-title":"Cancer Res"},{"issue":"5897","key":"BF6605225_CR50","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz Jr LA, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321 (5897): 1807\u20131812","journal-title":"Science"},{"key":"BF6605225_CR51","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1535-6108(03)00089-8","volume":"3","author":"K Pietras","year":"2003","unstructured":"Pietras K, Sjoblom T, Rubin K, Heldin CH, Ostman A (2003) PDGF receptors as cancer drug targets. Cancer Cell 3: 439\u2013443","journal-title":"Cancer Cell"},{"key":"BF6605225_CR52","first-page":"529","volume":"67","author":"KH Plate","year":"1992","unstructured":"Plate KH, Breier G, Farrell CL, Risau W (1992) Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas. Lab Invest 67: 529\u2013534","journal-title":"Lab Invest"},{"key":"BF6605225_CR53","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1158\/1541-7786.MCR-06-0085","volume":"4","author":"M Puputti","year":"2006","unstructured":"Puputti M, Tynninen O, Sihto H, Blom T, Maenpaa H, Isola J, Paetau A, Joensuu H, Nupponen NN (2006) Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas. Mol Cancer Res 4: 927\u2013934","journal-title":"Mol Cancer Res"},{"key":"BF6605225_CR54","doi-asserted-by":"publisher","first-page":"14344","DOI":"10.1073\/pnas.0507200102","volume":"102","author":"V Rand","year":"2005","unstructured":"Rand V, Huang J, Stockwell T, Ferriera S, Buzko O, Levy S, Busam D, Li K, Edwards JB, Eberhart C, Murphy KM, Tsiamouri A, Beeson K, Simpson AJ, Venter JC, Riggins GJ, Strausberg RL (2005) Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas. Proc Natl Acad Sci USA 102: 14344\u201314349","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6605225_CR55","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1200\/JCO.2008.16.9235","volume":"26","author":"E Raymond","year":"2008","unstructured":"Raymond E, Brandes AA, Dittrich C, Fumoleau P, Coudert B, Clement PM, Frenay M, Rampling R, Stupp R, Kros JM, Heinrich MC, Gorlia T, Lacombe D, van den Bent MJ, European Organisation for Research and Treatment of Cancer Brain Tumor Group Study (2008) Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study. J Clin Oncol 26: 4659\u20134665","journal-title":"J Clin Oncol"},{"key":"BF6605225_CR56","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1215\/15228517-2008-003","volume":"10","author":"DA Reardon","year":"2008","unstructured":"Reardon DA, Desjardins A, Vredenburgh JJ, Sathornsumetee S, Rich JN, Quinn JA, Lagattuta TF, Egorin MJ, Gururangan S, McLendon R, Herndon JE, Friedman AH, Salvado AJ, Friedman HS (2008) Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: Phase 1 trial in adults with malignant glioma. Neuro Oncol 10: 330\u2013340","journal-title":"Neuro Oncol"},{"key":"BF6605225_CR57","doi-asserted-by":"publisher","first-page":"9359","DOI":"10.1200\/JCO.2005.03.2185","volume":"23","author":"DA Reardon","year":"2005","unstructured":"Reardon DA, Egorin MJ, Quinn JA, Rich JN, Gururangan S, Vredenburgh JJ, Desjardins A, Sathornsumetee S, Provenzale JM, Herndon JE, Dowell JM, Badruddoja MA, McLendon RE, Lagattuta TF, Kicielinski KP, Dresemann G, Sampson JH, Friedman AH, Salvado AJ, Friedman HS (2005) Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme. J Clin Oncol 23: 9359\u20139368","journal-title":"J Clin Oncol"},{"key":"BF6605225_CR58","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/ng0708-809b","volume":"40","author":"JS Reis-Filho","year":"2008","unstructured":"Reis-Filho JS, Drury S, Lambros MB, Marchio C, Johnson N, Natrajan R, Salter J, Levey P, Fletcher O, Peto J, Ashworth A, Dowsett M (2008) ESR1 gene amplification in breast cancer: a common phenomenon? Nat Genet 40: 809\u2013810","journal-title":"Nat Genet"},{"key":"BF6605225_CR59","first-page":"319","volume":"27","author":"RM Reis","year":"2005","unstructured":"Reis RM, Martins A, Ribeiro SA, Basto D, Longatto-Filho A, Schmitt FC, Lopes JM (2005) Molecular characterization of PDGFR-alpha\/PDGF-A and c-KIT\/SCF in gliosarcomas. Cell Oncol 27: 319\u2013326","journal-title":"Cell Oncol"},{"key":"BF6605225_CR60","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1136\/jnnp.72.6.782","volume":"72","author":"D Ribom","year":"2002","unstructured":"Ribom D, Andrae J, Frielingsdorf M, Hartman M, Nister M, Smits A (2002) Prognostic value of platelet derived growth factor alpha receptor expression in grade 2 astrocytomas and oligoastrocytomas. J Neurol Neurosurg Psychiatry 72: 782\u2013787","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF6605225_CR61","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0092-8674(88)90392-3","volume":"53","author":"WD Richardson","year":"1988","unstructured":"Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois Dalcq M (1988) A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 53: 309\u2013319","journal-title":"Cell"},{"key":"BF6605225_CR62","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/jcp.20659","volume":"208","author":"T Servidei","year":"2006","unstructured":"Servidei T, Riccardi A, Sanguinetti M, Dominici C, Riccardi R (2006) Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation. J Cell Physiol 208: 220\u2013228","journal-title":"J Cell Physiol"},{"key":"BF6605225_CR63","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.canlet.2005.02.002","volume":"232","author":"AH Shih","year":"2006","unstructured":"Shih AH, Holland EC (2006) Platelet-derived growth factor (PDGF) and glial tumorigenesis. Cancer Lett 232: 139\u2013147","journal-title":"Cancer Lett"},{"key":"BF6605225_CR64","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1750-3639.2008.00189.x","volume":"19","author":"FA Siebzehnrubl","year":"2008","unstructured":"Siebzehnrubl FA, Jeske I, M\u00fcller D, Buslei R, Coras R, Hahnen E, Huttner HB, Corbeil D, Kaesbauer J, Appl T, von H\u00f6rsten S, Bl\u00fcmcke I (2008) Spontaneous in vitro transformation of adult neural precursors into stem-like cancer cells. Brain Pathol 19: 399\u2013408","journal-title":"Brain Pathol"},{"key":"BF6605225_CR65","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1200\/JCO.2005.02.093","volume":"23","author":"H Sihto","year":"2005","unstructured":"Sihto H, Sarlomo-Rikala M, Tynninen O, Tanner M, Andersson LC, Franssila K, Nupponen NN, Joensuu H (2005) KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors. J Clin Oncol 23: 49\u201357","journal-title":"J Clin Oncol"},{"key":"BF6605225_CR66","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/jnen\/59.6.495","volume":"59","author":"JS Smith","year":"2000","unstructured":"Smith JS, Wang XY, Qian J, Hosek SM, Scheithauer BW, Jenkins RB, James CD (2000) Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features. J Neuropathol Exp Neurol 59: 495\u2013503","journal-title":"J Neuropathol Exp Neurol"},{"key":"BF6605225_CR67","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11060-007-9455-7","volume":"86","author":"H Takei","year":"2008","unstructured":"Takei H, Yogeswaren ST, Wong KK, Mehta V, Chintagumpala M, Dauser RC, Lau CC, Adesina AM (2008) Expression of oligodendroglial differentiation markers in pilocytic astrocytomas identifies two clinical subsets and shows a significant correlation with proliferation index and progression free survival. J Neuro Oncol 86: 183\u2013190","journal-title":"J Neuro Oncol"},{"key":"BF6605225_CR68","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1158\/1078-0432.CCR-07-1616","volume":"14","author":"HK Thorarinsdottir","year":"2008","unstructured":"Thorarinsdottir HK, Santi M, McCarter R, Rushing EJ, Cornelison R, Jales A, MacDonald TJ (2008) Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas. Clin Cancer Res 14: 3386\u20133394","journal-title":"Clin Cancer Res"},{"key":"BF6605225_CR69","first-page":"5275","volume":"58","author":"L Uhrbom","year":"1998","unstructured":"Uhrbom L, Hesselager G, Nister M, Westermark B (1998) Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res 58: 5275\u20135279","journal-title":"Cancer Res"},{"key":"BF6605225_CR70","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/jso.20036","volume":"86","author":"M Varela","year":"2004","unstructured":"Varela M, Ranuncolo SM, Morand A, Lastiri J, De Kier Joffe EB, Puricelli LI, Pallotta MG (2004) EGF-R and PDGF-R, but not bcl-2, overexpression predict overall survival in patients with low-grade astrocytomas. J Surg Oncol 86: 34\u201340","journal-title":"J Surg Oncol"},{"key":"BF6605225_CR71","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1056\/NEJMra0708126","volume":"359","author":"PY Wen","year":"2008","unstructured":"Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359: 492\u2013507","journal-title":"N Engl J Med"},{"key":"BF6605225_CR72","doi-asserted-by":"publisher","first-page":"4899","DOI":"10.1158\/1078-0432.CCR-06-0773","volume":"12","author":"PY Wen","year":"2006","unstructured":"Wen PY, Yung WKA, Lamborn KR, Dahia PL, Wang YF, Peng B, Abrey LE, Raizer J, Cloughesy TF, Fink K, Gilbert M, Chang S, Junck L, Schiff D, Lieberman F, Fine HA, Mehta M, Robins HI, DeAngelis LM, Groves MD, Puduvalli VK, Levin V, Conrad C, Maher EA, Aldape K, Hayes M, Letvak L, Egorin MJ, Capdeville R, Kaplan R, Murgo AJ, Stiles C, Prados MD (2006) Phase I\/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Clin Cancer Res 12: 4899\u20134907","journal-title":"Clin Cancer Res"},{"key":"BF6605225_CR73","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/glia.440150307","volume":"15","author":"B Westermark","year":"1995","unstructured":"Westermark B, Heldin CH, Nister M (1995) Platelet-derived growth factor in human glioma. Glia 15: 257\u2013263","journal-title":"Glia"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6605225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605225","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:41:13Z","timestamp":1684413673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6605225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,25]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["BF6605225"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6605225","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,25]]}}}